Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,050 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive breast cancer treated with tamoxifen.
Muss HB, Bunn JY, Crocker A, Plaut K, Koh J, Heintz N, Rincon M, Weaver DL, Tam D, Beatty B, Kaufman P, Donovan M, Verbel D, Weiss L. Muss HB, et al. Among authors: weiss l. Breast J. 2007 Jul-Aug;13(4):337-45. doi: 10.1111/j.1524-4741.2007.00440.x. Breast J. 2007. PMID: 17593037
Characterisation of Platelet Releasate Proteome in Relapsing-Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics.
Parsons M, O'Connell K, Szklanna P, Weiss L, Kenny M, Donnelly A, Norris J, Babyuk Y, O'Donoghue L, Ní Áinle F, McGuigan C, Maguire PB. Parsons M, et al. Among authors: weiss l. Proteomics Clin Appl. 2025 Jan 20:e202400019. doi: 10.1002/prca.202400019. Online ahead of print. Proteomics Clin Appl. 2025. PMID: 39831369
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Rinnerthaler G, Egle D, Bartsch R, Schmitt CA, Petzer A, Balic M, Petru E, Denison U, Singer CF, Bjelic-Radisic V, Gampenrieder SP, Knauer M, Sotlar K, Brunner C, Posch F, Hlauschek D, Sölkner L, Bago-Horvath Z, Filipits M, Gili M, Ritter M, Wieser V, Albertini C, Zaborsky N, Weiss L, Marhold M, Schneeweiss B, Pusch R, Gnant M, Greil R. Rinnerthaler G, et al. Among authors: weiss l. Nat Cancer. 2025 Jan 16. doi: 10.1038/s43018-024-00890-2. Online ahead of print. Nat Cancer. 2025. PMID: 39820125
3,050 results